NovoCure Limited (NASDAQ:NVCR) Q2 2023 Earnings Call Transcript July 27, 2023
NovoCure Limited beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.5.
Operator: Good day, and thank you for standing by. Welcome to the NovoCure Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being...
